NEW YORK (TheStreet) -- CHANGE IN RATINGS
downgraded at FBR from Outperform to Market Perform. $11 price target. Macro risks could hurt PC sales.
upgraded at BofA/Merrill COP upgraded to Neutral from Sell on 2Q10 EPS beat. Accelerated sale of its entire Lukoil stake leads us to neutralize our negative view. Maintain $61 price target.
upgraded at Baird from Neutral to Outperform. $60 price target. XenDesktop demand continues to accelerate.
upgraded at Citi to Hold from Sell. Acceleration in desktop license removes a major concern. Price target increased to $49 from $39.
downgraded at BofA/Merrill to Neutral from Buy on weak 2Q10 results. Missed on revenue and profitability. Price target reduced to $34 from $40.
estimates lowered at UBS through 2011. Company is seeing lower retail sales and dilution from the AET deal. Buy rating and $46 price target.
upgraded at Baird from Neutral to Outperform. $50 price target. Business trends are improving, which could lead to future earnings upside.
upgraded at Oppenheimer to Outperform. $115 price target. Growth visibility is improving, especially given the SDXC acquisition.
price target lower at Barclays by dollar to $10. MTW beats on crane margins, revenues down. Maintain Underweight rating.
( NETL) downgraded at UBS from Buy to Neutral. $33.50 price target. Company is realizing less operating leverage and has limited near-term catalysts.
downgraded at Deutsche Bank to Hold from Buy on implications from STP nuclear plans. Price target reduced to $25 from $27.
estimates, target reduced at Morgan Stanley. NVDA estimates were cut through 2012. Company reduced its guidance, as the company is out of position for the current product cycle. Underweight rating and new $9 price target.
downgraded at FBR from Outperform to Market Perform. $10 price target. Company cut guidance and is losing share at AAPL.
initiated at Barclays with an Overweight rating and $46 price target. Barclays noted strong production growth and high-quality assets.
upgraded at Credit Suisse to Outperform from Neutral as the company recently announced IQstream mobile broadband bandwidth optimization solution. Price target surged to $31 from $22.
Sun Life Financial
assumed at Barclays with an Overweight rating, up from Equal Weight. Sun Life is not as exposed to volatility in the capital markets, Barclays said. Price target sunk to $31 from $57.
downgraded at BofA/Merrill to Neutral from Buy on integration and macro risks. Price target lowered to $16 from $19.
estimates reduced at Morgan Stanley through 2013. License revenue has been halved over the past 18 months and margins continue to fall. Equal-weight rating.
downgraded at FBR from Outperform to Market Perform. $15 price target. Company had a poor quarter, as some storage deals have been delayed.
downgraded at Janney to Neutral from Buy on uncertainties related to near term operating issues, Janney Montgomery said.
upgraded at Barclays to Equal weight from Underweight. WSM demonstrated that it can quickly scale its expense structure and inventory position to match the environment. Price target jumped to $28 from $24.
STOCK COMMENTS / EPS CHANGES
price target higher at Credit Suisse to $35 from $32.50 on strong June results, mainly driven by growth in the Media & Entertainment and Commerce verticals. Neutral rating.
numbers increased at UBS. ARW estimates were raised through 2011. Company continues to see healthy demand. Buy rating and new $31 price target.
Canadian Pacific Railways
target boosted at Credit Suisse to $80 from $75 on robust 2Q10 earnings. Maintain Outperform rating.
estimates, target reduced at UBS. CTV estimates were cut through 2011. Company is seeing weaker international wireless demand. Neutral rating and new $28 price target.
estimates raised at Morgan Stanley. DECK estimates were increased through 2011, according to Morgan Stanley. Company is realizing a higher gross margin. Equal-weight rating.
price target cut at Credit Suisse to $26.50 from $28 as June quarter revenue was slightly below consensus. Maintain Neutral rating.
estimates lowered at Morgan Stanley through 2012. Company is seeing lower sales growth, as well as currency losses. Equal-weight rating.
estimates upped at UBS through 2011. Sales of gorilla glass continue to ramp. Buy rating and $25 price target.
( GSIC) estimates reduced at Morgan Stanley through 2012. Company is investing more on technology. Overweight rating.
target increased at Morgan Stanley. LRCX target was raised to $45. Company is gaining market share. Overweight rating.
Las Vegas Sands
numbers raised at UBS. Shares of LVS now seen reaching $32. Estimates also increased, given better results in Singapore. Buy rating.
Old Dominion Freight Line
price target lifted at Credit Suisse. ODFL price target climbed to $40 from $36. Solid earnings beat from greater operating leverage. Maintain Underperform rating.
estimates, target boosted at Morgan Stanley. Shares of PX now seen reaching $92, according to Morgan Stanley. Estimates also upped, as the company has a deep pipeline and considerable operating leverage. Eqaul-weight rating.
estimates upped at Morgan Stanley. ROK estimates were boosted through 2011, Morgan Stanley said. Company raised its guidance, given continued sales growth and margin expansion. Equal-weight rating and $62 price target.
price target cut at Credit Suisse. SYMC price target reduced to $16.50 from $22. Lackluster 1Q10 results with weak margins, Credit Suisse said. Maintain Outperform rating.
estimates cut at Morgan Stanley. VPRT estimates were reduced through 2012, according to Morgan Stanley. Company lowered guidance, because of softer demand in Europe. Equal-weight rating.
estimates increased at Morgan Stanley. WAT estimates were raised through 2012, Morgan Stanley said. Organic growth is improving. Equal-weight rating.
estimates cut at Morgan Stanley. ZION estimates were lowered through 2012, Morgan Stanley said. Total return swaps will help reduce risk, but still cut into earnings. Overweight rating and $34 price target.
This article was written by a staff member of TheStreet.